Juvion Health Sciences

Science to Sustain Motion

We aim to preserve motor function and mobility with next-generation therapeutics supported by cutting-edge science

OUR MISSION

Improving Healthspan and Preserving mobility for Active Aging

In adults over 60 - 1/3 Suffer from significant mobility issues | 80% live with at least one chronic condition | 50% live with at least two chronic conditions.

The Challenge

An aging population increases immobility, neuropathy and sarcopenia, driving up healthcare costs, straining economic systems and diminishing life quality.

Our Solution

Preserving neuron-muscle communication with next-generation therapeutics isolated using our proprietary technology to safeguard motor ability during aging.

The Opportunity

The aging therapeutics and diagnostics market is projected to reach $1.5 trillion by 2030

Our Record

Our foundational research has been published in top-tier science journals and our technology is patent pending.

Motor Aging Neuroscience

Aging causes deterioration of the connection of motor terminals from neurons in the spine to muscles, resulting in weakness and reduced motor ability

Motor Aging Technology

Our proprietary screening technology platform combines robotics, machine vision and AI analysis to quantitatively assess motor ability in vivo during aging.

Motor Aging Therapeutics

We have focused on naturally-derived compounds which, while equally efficacious, offer fewer regulatory hurdles to enable a rapid transition to market availability.

Motor Aging Benefits

Compounds identified using our screening platform are validated across multiple assays for robust data-supported improvement of motor ability during aging.

Juvion 001

Our first product candidate Juvion-001 is a plant-derived supplement that increases motor ability during middle and old age in multiple assays of motor function during aging.

Juvion-001 is science supported and expected to become available in select markets in 2026 to promote motor health during aging.